UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

BMC psychiatry, 2021-05, Vol.21 (1), p.249-249, Article 249

2021

Volltextzugriff (PDF)

Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis

Chronic Respiratory Disease, 2020, Vol.17, p.1479973119901234

2020

Volltextzugriff (PDF)

The economic and humanistic burden of bipolar disorder in adults in the United States

Annals of general psychiatry, 2023-03, Vol.22 (1), p.13-13, Article 13

2023

Volltextzugriff (PDF)

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

Patient preference and adherence, 2011-01, Vol.5 (default), p.73-84

2011

Volltextzugriff (PDF)

Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia

Schizophrenia research. Cognition, 2022-06, Vol.28, p.100233-100233, Article 100233

2022

Volltextzugriff (PDF)

Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data

Current therapeutic research, 2021-01, Vol.94, p.100629-100629, Article 100629

2021

Volltextzugriff (PDF)

INHALATION DEVICE TECHNIQUE ERRORS AMONG PATIENTS WITH OBSTRUCTIVE LUNG DISEASES USING METERED-DOSE INHALERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF US STUDIES

Chest, 2018-10, Vol.154 (4), p.784A-785A

2018

Volltextzugriff (PDF)

Payer Costs in Patients Undergoing Uterine Artery Embolization, Hysterectomy, or Myomectomy for Treatment of Uterine Fibroids

Journal of vascular and interventional radiology, 2007-10, Vol.18 (10), p.1207-1213

2007

Volltextzugriff (PDF)

Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators

Clinical therapeutics, 2019-11, Vol.41 (11), p.2283-2296

2019

Volltextzugriff (PDF)

The Incidence and Economic Burden of Extrapyramidal Symptoms in Patients with Schizophrenia Initiating Atypical Antipsychotics in a Commercially Insured Population

CNS spectrums, 2022-04, Vol.27 (2), p.228-228

2022

Volltextzugriff (PDF)

Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis

Current medical research and opinion, 2022-09, Vol.38 (9), p.1613-1619

2022

Volltextzugriff (PDF)

A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia

BMJ open, 2024-07, Vol.14 (7), p.e084613

2024

Volltextzugriff (PDF)

Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis

Medicine (Baltimore), 2020-06, Vol.99 (25), p.e20718-e20718

2020

Volltextzugriff (PDF)

CLINICALLY IMPORTANT DETERIORATION AMONG PATIENTS WITH COPD TREATED WITH GLYCOPYRROLATE EFLOW CS OR TIOTROPIUM IN A LONG-TERM OPEN-LABEL STUDY

Chest, 2018-10, Vol.154 (4), p.777A-778A

2018

Volltextzugriff (PDF)

Burden of EPS in Commercial Patients With Schizophrenia Initiating Atypical Antipsychotics

The American journal of managed care, 2022-09, Vol.28 (9), p.1

2022

Volltextzugriff (PDF)

Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies

Chronic obstructive pulmonary diseases, 2019-07, Vol.6 (3), p.267-280

2019

Volltextzugriff (PDF)

Assessing the Risk of Health, Social, and Fiscal Events in Schizophrenia According to Remission or Relapse Status Using Real World Data from a SCZ Survey in the US

CNS spectrums, 2022-04, Vol.27 (2), p.225-226

2022

Volltextzugriff (PDF)

The Economic Burden of Schizophrenia in the United States in 2019

CNS spectrums, 2022-04, Vol.27 (2), p.227-227

2022

Volltextzugriff (PDF)

Real-World Outcomes Associated with Cognitive Impairment Among Patients with Schizophrenia

CNS spectrums, 2022-04, Vol.27 (2), p.254-254

2022

Volltextzugriff (PDF)

Healthcare Resource Use and Quality of Life Associated with Cognitive Impairment Among Patients with Schizophrenia

CNS spectrums, 2022-04, Vol.27 (2), p.227-227

2022

Volltextzugriff (PDF)

Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US

Current medical research and opinion, 2022-03, Vol.38 (3), p.469-478

2022

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS AND MEDICATION MANAGEMENT OF LONG-TERM CARE RESIDENTS WITH COPD IN NURSING FACILITIES

Chest, 2019-10, Vol.156 (4), p.A457-A458

2019

Volltextzugriff (PDF)

DEVICE USE ERRORS WITH SOFT MIST INHALERS IN PATIENTS WITH COPD: A GLOBAL META-ANALYSIS

Chest, 2019-10, Vol.156 (4), p.A1601-A1602

2019

Volltextzugriff (PDF)

ASSESSMENT OF PEAK INSPIRATORY FLOW RATES AND MEDICAL MANAGEMENT OF COPD IN NURSING FACILITY RESIDENTS

Chest, 2019-10, Vol.156 (4), p.A1748-A1749

2019

Volltextzugriff (PDF)

Psychiatric Inpatient Healthcare Resource Utilization and Treatment Patterns Among Patients With Predominant Negative Symptoms in Schizophrenia

CNS spectrums, 2023-04, Vol.28 (2), p.222-223

2023

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(26)
Chronic Obstructive Pulmonary Disease
(13)
Schizophrenia
(12)
General & Internal Medicine
(11)
Medicine, General & Internal
(11)
Original Research
(10)
Respiratory System
(10)
Health Care Sciences & Services
(9)
Hospitalization
(9)
Retrospective Studies
(9)
United States
(9)
Abstracts
(8)
Medicare
(8)
Adult
(7)
Aged
(7)
Antipsychotics
(7)
Female
(7)
Quality Of Life
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis

The economic and humanistic burden of bipolar disorder in adults in the United States

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia

Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data

INHALATION DEVICE TECHNIQUE ERRORS AMONG PATIENTS WITH OBSTRUCTIVE LUNG DISEASES USING METERED-DOSE INHALERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF US STUDIES

Payer Costs in Patients Undergoing Uterine Artery Embolization, Hysterectomy, or Myomectomy for Treatment of Uterine Fibroids

Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators

The Incidence and Economic Burden of Extrapyramidal Symptoms in Patients with Schizophrenia Initiating Atypical Antipsychotics in a Commercially Insured Population

Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis

A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia

Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis

CLINICALLY IMPORTANT DETERIORATION AMONG PATIENTS WITH COPD TREATED WITH GLYCOPYRROLATE EFLOW CS OR TIOTROPIUM IN A LONG-TERM OPEN-LABEL STUDY

Burden of EPS in Commercial Patients With Schizophrenia Initiating Atypical Antipsychotics

Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies

Assessing the Risk of Health, Social, and Fiscal Events in Schizophrenia According to Remission or Relapse Status Using Real World Data from a SCZ Survey in the US

The Economic Burden of Schizophrenia in the United States in 2019

Real-World Outcomes Associated with Cognitive Impairment Among Patients with Schizophrenia

Healthcare Resource Use and Quality of Life Associated with Cognitive Impairment Among Patients with Schizophrenia

Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US

CLINICAL CHARACTERISTICS AND MEDICATION MANAGEMENT OF LONG-TERM CARE RESIDENTS WITH COPD IN NURSING FACILITIES

DEVICE USE ERRORS WITH SOFT MIST INHALERS IN PATIENTS WITH COPD: A GLOBAL META-ANALYSIS

ASSESSMENT OF PEAK INSPIRATORY FLOW RATES AND MEDICAL MANAGEMENT OF COPD IN NURSING FACILITY RESIDENTS

Psychiatric Inpatient Healthcare Resource Utilization and Treatment Patterns Among Patients With Predominant Negative Symptoms in Schizophrenia

Suchergebnisse filtern